Bilirubin Meters Market By Product , By Indication By Age Group By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

The bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.

The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.

The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the transcutaneous segment dominated the market share in 2023.

On the basis of indication, the jaundice segment was the major shareholder in 2023.

As per age group, neonatal emerged as the leading segment in 2023.

Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.

Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bilirubin meters market include APEL Co. Ltd., Dragerwerk AG & Co. KGaA, Mennen Medical Ltd, Micro Lab Instruments, Ningbo David Medical Device Co. Ltd., Siemens Healthineers AG, Micro Labs Instruments, AVI Healthcare Pvt Ltd, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

By Product

Bench-Top
Transcutaneous

By Indication

Jaundice
Hepatitis

By Age Group

Neonatal
Adults

By End User

Hospitals and Nursing Home
Clinics
Others

Key Market Players:

APEL Co. Ltd
Dragerwerk AG & Co. KGaA
Mennen Medical Ltd
Micro Lab Instruments
Ningbo David Medical Device Co. Ltd
Siemens Healthineers AG
Micro Labs Instruments
AVI Healthcare Pvt Ltd
F. Hoffmann-La Roche Ltd.
Koninklijke Philips N.V.

Product Code: A324070

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: BILIRUBIN METERS MARKET, BY PRODUCT

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
4.2. Bench-Top
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Transcutaneous
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country

CHAPTER 5: BILIRUBIN METERS MARKET, BY INDICATION

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Indication
5.2. Jaundice
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Hepatitis
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country

CHAPTER 6: BILIRUBIN METERS MARKET, BY AGE GROUP

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Age Group
6.2. Neonatal
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Adults
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country

CHAPTER 7: BILIRUBIN METERS MARKET, BY END USER

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End User
7.2. Hospitals And Nursing Home
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
7.3. Clinics
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
7.4. Others
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country

CHAPTER 8: BILIRUBIN METERS MARKET, BY REGION

8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product
- 8.2.3. Market Size and Forecast, By Indication
- 8.2.4. Market Size and Forecast, By Age Group
- 8.2.5. Market Size and Forecast, By End User
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Bilirubin Meters Market
  - 8.2.7.1. Market Size and Forecast, By Product
  - 8.2.7.2. Market Size and Forecast, By Indication
  - 8.2.7.3. Market Size and Forecast, By Age Group
  - 8.2.7.4. Market Size and Forecast, By End User
- 8.2.8. Canada Bilirubin Meters Market
  - 8.2.8.1. Market Size and Forecast, By Product
  - 8.2.8.2. Market Size and Forecast, By Indication
  - 8.2.8.3. Market Size and Forecast, By Age Group
  - 8.2.8.4. Market Size and Forecast, By End User
- 8.2.9. Mexico Bilirubin Meters Market
  - 8.2.9.1. Market Size and Forecast, By Product
  - 8.2.9.2. Market Size and Forecast, By Indication
  - 8.2.9.3. Market Size and Forecast, By Age Group
  - 8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product
- 8.3.3. Market Size and Forecast, By Indication
- 8.3.4. Market Size and Forecast, By Age Group
- 8.3.5. Market Size and Forecast, By End User
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. Germany Bilirubin Meters Market
  - 8.3.7.1. Market Size and Forecast, By Product
  - 8.3.7.2. Market Size and Forecast, By Indication
  - 8.3.7.3. Market Size and Forecast, By Age Group
  - 8.3.7.4. Market Size and Forecast, By End User
- 8.3.8. France Bilirubin Meters Market
  - 8.3.8.1. Market Size and Forecast, By Product
  - 8.3.8.2. Market Size and Forecast, By Indication
  - 8.3.8.3. Market Size and Forecast, By Age Group
  - 8.3.8.4. Market Size and Forecast, By End User
- 8.3.9. UK Bilirubin Meters Market
  - 8.3.9.1. Market Size and Forecast, By Product
  - 8.3.9.2. Market Size and Forecast, By Indication
  - 8.3.9.3. Market Size and Forecast, By Age Group
  - 8.3.9.4. Market Size and Forecast, By End User
- 8.3.10. Italy Bilirubin Meters Market
  - 8.3.10.1. Market Size and Forecast, By Product
  - 8.3.10.2. Market Size and Forecast, By Indication
  - 8.3.10.3. Market Size and Forecast, By Age Group
  - 8.3.10.4. Market Size and Forecast, By End User
- 8.3.11. Spain Bilirubin Meters Market
  - 8.3.11.1. Market Size and Forecast, By Product
  - 8.3.11.2. Market Size and Forecast, By Indication
  - 8.3.11.3. Market Size and Forecast, By Age Group
  - 8.3.11.4. Market Size and Forecast, By End User
- 8.3.12. Rest of Europe Bilirubin Meters Market
  - 8.3.12.1. Market Size and Forecast, By Product
  - 8.3.12.2. Market Size and Forecast, By Indication
  - 8.3.12.3. Market Size and Forecast, By Age Group
  - 8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product
- 8.4.3. Market Size and Forecast, By Indication
- 8.4.4. Market Size and Forecast, By Age Group
- 8.4.5. Market Size and Forecast, By End User
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. Japan Bilirubin Meters Market
  - 8.4.7.1. Market Size and Forecast, By Product
  - 8.4.7.2. Market Size and Forecast, By Indication
  - 8.4.7.3. Market Size and Forecast, By Age Group
  - 8.4.7.4. Market Size and Forecast, By End User
- 8.4.8. China Bilirubin Meters Market
  - 8.4.8.1. Market Size and Forecast, By Product
  - 8.4.8.2. Market Size and Forecast, By Indication
  - 8.4.8.3. Market Size and Forecast, By Age Group
  - 8.4.8.4. Market Size and Forecast, By End User
- 8.4.9. Australia Bilirubin Meters Market
  - 8.4.9.1. Market Size and Forecast, By Product
  - 8.4.9.2. Market Size and Forecast, By Indication
  - 8.4.9.3. Market Size and Forecast, By Age Group
  - 8.4.9.4. Market Size and Forecast, By End User
- 8.4.10. India Bilirubin Meters Market
  - 8.4.10.1. Market Size and Forecast, By Product
  - 8.4.10.2. Market Size and Forecast, By Indication
  - 8.4.10.3. Market Size and Forecast, By Age Group
  - 8.4.10.4. Market Size and Forecast, By End User
- 8.4.11. South Korea Bilirubin Meters Market
  - 8.4.11.1. Market Size and Forecast, By Product
  - 8.4.11.2. Market Size and Forecast, By Indication
  - 8.4.11.3. Market Size and Forecast, By Age Group
  - 8.4.11.4. Market Size and Forecast, By End User
- 8.4.12. Rest of Asia-Pacific Bilirubin Meters Market
  - 8.4.12.1. Market Size and Forecast, By Product
  - 8.4.12.2. Market Size and Forecast, By Indication
  - 8.4.12.3. Market Size and Forecast, By Age Group
  - 8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product
- 8.5.3. Market Size and Forecast, By Indication
- 8.5.4. Market Size and Forecast, By Age Group
- 8.5.5. Market Size and Forecast, By End User
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Bilirubin Meters Market
  - 8.5.7.1. Market Size and Forecast, By Product
  - 8.5.7.2. Market Size and Forecast, By Indication
  - 8.5.7.3. Market Size and Forecast, By Age Group
  - 8.5.7.4. Market Size and Forecast, By End User
- 8.5.8. Saudi Arabia Bilirubin Meters Market
  - 8.5.8.1. Market Size and Forecast, By Product
  - 8.5.8.2. Market Size and Forecast, By Indication
  - 8.5.8.3. Market Size and Forecast, By Age Group
  - 8.5.8.4. Market Size and Forecast, By End User
- 8.5.9. South Africa Bilirubin Meters Market
  - 8.5.9.1. Market Size and Forecast, By Product
  - 8.5.9.2. Market Size and Forecast, By Indication
  - 8.5.9.3. Market Size and Forecast, By Age Group
  - 8.5.9.4. Market Size and Forecast, By End User
- 8.5.10. Rest of LAMEA Bilirubin Meters Market
  - 8.5.10.1. Market Size and Forecast, By Product
  - 8.5.10.2. Market Size and Forecast, By Indication
  - 8.5.10.3. Market Size and Forecast, By Age Group
  - 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

10.1. APEL Co. Ltd
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
10.2. Dragerwerk AG And Co. KGaA
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
10.3. Mennen Medical Ltd
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
10.4. Micro Lab Instruments
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
10.5. Ningbo David Medical Device Co. Ltd
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
10.6. Siemens Healthineers AG
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
10.7. Micro Labs Instruments
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
10.8. AVI Healthcare Pvt Ltd
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
10.9. F. Hoffmann-La Roche Ltd.
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
10.10. Koninklijke Philips N.V.
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments